CBD Global Sciences Inc. Logo

CBD Global Sciences Inc.

CBDNF

(2.2)
Stock Price

0,04 USD

-298.58% ROA

105.36% ROE

-0.28x PER

Market Cap.

2.072.232,00 USD

-140.66% DER

0% Yield

-3146.33% NPM

CBD Global Sciences Inc. Stock Analysis

CBD Global Sciences Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CBD Global Sciences Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (105.36%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

The stock's low PBV ratio (-0.66x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-141%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

5 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

6 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

7 ROA

The stock's ROA (-298.58%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

CBD Global Sciences Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CBD Global Sciences Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

CBD Global Sciences Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CBD Global Sciences Inc. Revenue
Year Revenue Growth
2019 2.317.138
2020 305.400 -658.72%
2021 166.947 -82.93%
2022 961.024 82.63%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CBD Global Sciences Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2019 71.985
2020 35.917 -100.42%
2021 7.137 -403.25%
2022 14.732 51.55%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CBD Global Sciences Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 2.859.087
2020 2.109.876 -35.51%
2021 1.910.747 -10.42%
2022 1.442.644 -32.45%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CBD Global Sciences Inc. EBITDA
Year EBITDA Growth
2019 -2.066.741
2020 -2.492.515 17.08%
2021 -2.673.850 6.78%
2022 -695.500 -284.45%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CBD Global Sciences Inc. Gross Profit
Year Gross Profit Growth
2019 1.433.246
2020 -187.061 866.19%
2021 40.999 556.26%
2022 885.924 95.37%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CBD Global Sciences Inc. Net Profit
Year Net Profit Growth
2019 -8.956.222
2020 -8.927.702 -0.32%
2021 -5.252.701 -69.96%
2022 -1.237.612 -324.42%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CBD Global Sciences Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 -1
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CBD Global Sciences Inc. Free Cashflow
Year Free Cashflow Growth
2019 -2.147.804
2020 -1.339.790 -60.31%
2021 -1.141.610 -17.36%
2022 19.854 5850.03%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CBD Global Sciences Inc. Operating Cashflow
Year Operating Cashflow Growth
2019 -1.937.473
2020 -1.339.790 -44.61%
2021 -1.138.610 -17.67%
2022 19.854 5834.91%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CBD Global Sciences Inc. Capital Expenditure
Year Capital Expenditure Growth
2019 210.331
2020 0 0%
2021 3.000 100%
2022 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CBD Global Sciences Inc. Equity
Year Equity Growth
2019 -1.158.225
2020 -8.275.408 86%
2021 -1.695.861 -387.98%
2022 -3.118.836 45.63%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CBD Global Sciences Inc. Assets
Year Assets Growth
2019 6.148.380
2020 472.477 -1201.31%
2021 2.091.593 77.41%
2022 1.625.526 -28.67%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CBD Global Sciences Inc. Liabilities
Year Liabilities Growth
2019 7.306.605
2020 8.747.885 16.48%
2021 3.787.454 -130.97%
2022 4.744.362 20.17%

CBD Global Sciences Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.15
Price to Earning Ratio
-0.28x
Price To Sales Ratio
12.41x
POCF Ratio
-1.31
PFCF Ratio
-1.82
Price to Book Ratio
-0.88
EV to Sales
26.14
EV Over EBITDA
-1.63
EV to Operating CashFlow
-3.83
EV to FreeCashFlow
-3.82
Earnings Yield
-3.51
FreeCashFlow Yield
-0.55
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.4
Graham NetNet
-0.1

Income Statement Metrics

Net Income per Share
-0.15
Income Quality
0.22
ROE
1.05
Return On Assets
-2.51
Return On Capital Employed
-76.34
Net Income per EBT
1.01
EBT Per Ebit
1.9
Ebit per Revenue
-16.41
Effective Tax Rate
-0.11

Margins

Sales, General, & Administrative to Revenue
11.45
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
4.12
Gross Profit Margin
0.25
Operating Profit Margin
-16.41
Pretax Profit Margin
-31.15
Net Profit Margin
-31.46

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.03
Free CashFlow per Share
-0.03
Capex to Operating CashFlow
0
Capex to Revenue
-0.02
Capex to Depreciation
-0.05
Return on Invested Capital
-2.6
Return on Tangible Assets
-2.99
Days Sales Outstanding
51.49
Days Payables Outstanding
947.89
Days of Inventory on Hand
548.05
Receivables Turnover
7.09
Payables Turnover
0.39
Inventory Turnover
0.67
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,05
Tangible Book Value per Share
-0.06
Shareholders Equity per Share
-0.05
Interest Debt per Share
0.08
Debt to Equity
-1.41
Debt to Assets
1.14
Net Debt to EBITDA
-0.86
Current Ratio
0.16
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-1.41
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.16
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
94556
Debt to Market Cap
1.15

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CBD Global Sciences Inc. Dividends
Year Dividends Growth

CBD Global Sciences Inc. Profile

About CBD Global Sciences Inc.

CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.

CEO
Mr. Brad Wyatt
Employee
0
Address
225 Union Boulevard
Lakewood, 80228

CBD Global Sciences Inc. Executives & BODs

CBD Global Sciences Inc. Executives & BODs
# Name Age
1 Mr. Brad Wyatt
Co-Founder, Chief Executive Officer, President & Director
70
2 Mr. Glenn Dooley
Interim Chief Financial Officer, Co-Founder, Chief Operating Officer, Company Secretary & Director
70

CBD Global Sciences Inc. Competitors